Novartis applauds Ontario’s bold leadership in launching the FAST program, which accelerates access to breakthrough therapies like Scemblix ® for patients living with cancer. Scemblix ® (asciminib) ...
Explore opportunities with Novartis below.
Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030 Enables manufacturing of medicines across company’s main therapeutic ...
Basel, November 20, 2025 – Novartis today rolled forward its mid-term guidance to 2025-2030 with a sales CAGR of +5-6% cc. The updated outlook will be featured at its Meet Novartis Management event in ...
Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030 Marks latest milestone in company’s previously announced $23 billion ...
America is facing a growing epidemic of chronic disease. Many of the most common chronic conditions, like cardiovascular disease and cancer, are often treatable. Yet for too many people, access to ...
ノバルティス ファーマ株式会社(本社:東京都港区、代表取締役社長:ジョンポール・プリシーノ)(以下「ノバルティス ファーマ」)は、日本の前立腺がんの治療経験に基づく視点を ...
Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical ...
חפשו אחר אפשרויות תעסוקה בחברת נוברטיס וסנדוז. לתפקידים נוספים ב Novartis Gene Therapies (formerly AveXis) בקרו בGTx Career Search הודעה למתמודדים על משרות בארה"ב.
Εξερευνήστε ευκαιρίες στη Novartis παρακάτω. Expert Scientific Writer Regular, Full time Development Ireland Dublin (NOCC) Δεκ 08, 2025 Associate Director, Global Publications & Foundational Content ...